Background Prostate-specific antigen (PSA) is a commonly used test to detect prostate
cancer. Attention has mostly focused on the use of PSA in screening asymptomatic patients …

Importance Prostate cancer is the second leading cause of cancer death among US men.
Objective To systematically review evidence on prostate-specific antigen (PSA)–based …

Background Screening for prostate cancer is burdened by a high rate of overdiagnosis. The
most appropriate algorithm for population-based screening is unknown. Methods We invited …

The NCCN Guidelines for Prostate Cancer Early Detection provide recommendations for
individuals with a prostate who opt to participate in an early detection program after …

Preeclampsia is a major cause of maternal and perinatal morbidity and mortality. Early-onset
disease requiring preterm delivery is associated with a higher risk of complications in both …

In this article, the American Cancer Society provides the estimated number of new cancer
cases and deaths for blacks in the United States and the most recent data on cancer …

Abstract Context Although prostate cancer (PCa) screening reduces the incidence of
advanced disease and mortality, trade-offs include overdiagnosis and resultant …

Purpose: The guideline purpose is to provide the urologist with a framework for the early
detection of prostate cancer in asymptomatic average risk men. Materials and Methods: A …

Purpose To analyze the baseline clinicopathologic characteristics of prostate tumors with
germline BRCA1 and BRCA2 (BRCA1/2) mutations and the prognostic value of those …

Background Several trials evaluating the effect of prostate-specific antigen (PSA) testing on
prostate-cancer mortality have shown conflicting results. We updated prostate-cancer …